Serious pulmonary toxicity in patients with Hodgkin’s lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism

Background: Based on in vitro synergistic cytotoxicity when anti-CD30 antibodies are combined with gemcitabine, the Cancer and Leukemia Group B conducted a double-blind, randomized, phase II trial of SGN-30 with gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD) in patients with rel...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Blum, K. A., Jung, S.-H., Johnson, J. L., Lin, T. S., Hsi, E. D., Lucas, D. M., Byrd, J. C., Cheson, B. D., Bartlett, N. L.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2010
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2962257/
https://ncbi.nlm.nih.gov/pubmed/20423913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdq211
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items